STOCK TITAN

[144] PTC THERAPEUTICS, INC. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

PTC Therapeutics (PTCT) filed a Form 144 notice for a proposed sale of 55,000 shares of common stock. The filing lists an aggregate market value of $3,632,946.95 for the shares and an approximate sale date of 10/03/2025. The designated broker is Fidelity Brokerage Services LLC, and the shares are listed on NASDAQ.

The shares were acquired via an option grant dated 01/04/2016, from the issuer, with payment noted as cash on 10/03/2025. The filing also reports 79,438,094 shares outstanding. This notice reflects an intention to sell under Rule 144 and does not itself execute a transaction.

PTC Therapeutics (PTCT) ha presentato un modulo Form 144 per una proposta di vendita di 55.000 azioni ordinarie. La richiesta riporta un valore di mercato aggregato di $3.632.946,95 per le azioni e una data di vendita approssimativa del 03/10/2025. Il broker designato è Fidelity Brokerage Services LLC, e le azioni sono quotate su NASDAQ.

Le azioni sono state acquisite tramite una concessione di opzioni datata 04/01/2016, dall’emittente, con pagamento indicato come contanti il 03/10/2025. Il modulo riporta anche 79.438.094 azioni in circolazione. Questo avviso riflette l’intenzione di vendere ai sensi della Regola 144 e non esegue di per sé una transazione.

PTC Therapeutics (PTCT) presentó un aviso Form 144 para una venta propuesta de 55,000 acciones ordinarias. El registro indica un valor de mercado agregado de $3,632,946.95 para las acciones y una fecha de venta aproximada del 03/10/2025. El corredor designado es Fidelity Brokerage Services LLC, y las acciones cotizan en NASDAQ.

Las acciones fueron adquiridas mediante una concesión de opciones con fecha 01/04/2016, del emisor, con pago indicado como efectivo el 03/10/2025. El registro también reporta 79,438,094 acciones en circulación. Este aviso refleja la intención de vender conforme a la Regla 144 y no ejecuta una transacción por sí mismo.

PTC Therapeutics (PTCT)는 일반주 55,000주 매도를 위한 Form 144 통지를 제출했습니다. 제출서는 주식의 총 시장가치를 3,632,946.95달러로 표시하고 매도 예정일은 대략 2025년 10월 3일입니다. 지정 중개인은 Fidelity Brokerage Services LLC이고 주식은 NASDAQ에 상장되어 있습니다.

주식은 발행사로부터 2016년 1월 4일로 날짜를 가진 옵션 부여를 통해 취득되었으며, 2025년 10월 3일 현금으로 지불된 것으로 표시됩니다. 제출서는 또한 79,438,094주가 발행 주식으로 남아 있음을 보고합니다. 이 공고는 규칙 144에 따른 매도 의사를 반영하며 자체적으로 거래를 실행하지 않습니다.

PTC Therapeutics (PTCT) a déposé un avis Form 144 pour une vente proposée de 55 000 actions ordinaires. Le dossier indique une valeur marchande brute de 3 632 946,95 USD pour les actions et une date de vente approximative du 3 octobre 2025. Le courtier désigné est Fidelity Brokerage Services LLC, et les actions sont cotées sur NASDAQ.

Les actions ont été acquises via une attribution d’options datée du 4 janvier 2016, par l’émetteur, le paiement étant noté comme espèces le 3 octobre 2025. Le dossier rapporte également 79 438 094 actions en circulation. Cet avis reflète l’intention de vendre conformément à la règle 144 et ne réalise pas lui-même une transaction.

PTC Therapeutics (PTCT) legte eine Form 144-Mitteilung für einen vorgeschlagenen Verkauf von 55.000 Stammaktien ein. Die Unterlage listet einen aggregierten Marktwert von 3.632.946,95 USD für die Aktien und ein voraussichtliches Verkaufsdatum vom 3. Oktober 2025. Der designated Broker ist Fidelity Brokerage Services LLC, und die Aktien sind an der NASDAQ notiert.

Die Aktien wurden durch eine Optionsgewährung vom 4. Januar 2016 vom Emittenten erworben, mit der Zahlung, die am 3. Oktober 2025 als Bargeld vermerkt ist. Die Unterlage meldet außerdem 79.438.094 ausstehende Aktien. Diese Mitteilung spiegelt die Absicht wider, gemäß Regel 144 zu verkaufen, und führt selbst keinen Handel aus.

PTC Therapeutics (PTCT) قدم إشعار Form 144 لبيع مقترح لـ 55,000 سهم عادي. يذكر الملف قيمة سوقية إجمالية قدرها 3,632,946.95 دولاراً للأسهم وتاريخ بيع تقريبي في 3 أكتوبر 2025. الوسيط المعين هو Fidelity Brokerage Services LLC، والأسهم مُدرجة في NASDAQ.

تم الحصول على الأسهم من خلال منحة خيارات بتاريخ 4 يناير 2016 من المصدر، مع ذكر الدفع كـ نقداً في 3 أكتوبر 2025. كما يُذكر في الملف وجود 79,438,094 سهمًا قائمًا. يعكس هذا الإشعار نية البيع بموجب القاعدة 144 ولا ينفذ صفقة بنفسه.

PTC Therapeutics (PTCT) 为拟议出售55,000股普通股提交了 Form 144 通知。该文件列出股票的 总市值为 $3,632,946.95,并且预计的出售日期为2025年10月3日。指定经纪人为 Fidelity Brokerage Services LLC,股票在 NASDAQ 上上市。

这些股票通过发行人日期为 2016年1月4日 的期权授予获取,支付在 2025年10月3日 被记为现金。文件还报告在外流通的股票为 79,438,094 股。本通知反映了依据规则 144 的出售意向,且本身并不执行交易。

Positive
  • None.
Negative
  • None.

PTC Therapeutics (PTCT) ha presentato un modulo Form 144 per una proposta di vendita di 55.000 azioni ordinarie. La richiesta riporta un valore di mercato aggregato di $3.632.946,95 per le azioni e una data di vendita approssimativa del 03/10/2025. Il broker designato è Fidelity Brokerage Services LLC, e le azioni sono quotate su NASDAQ.

Le azioni sono state acquisite tramite una concessione di opzioni datata 04/01/2016, dall’emittente, con pagamento indicato come contanti il 03/10/2025. Il modulo riporta anche 79.438.094 azioni in circolazione. Questo avviso riflette l’intenzione di vendere ai sensi della Regola 144 e non esegue di per sé una transazione.

PTC Therapeutics (PTCT) presentó un aviso Form 144 para una venta propuesta de 55,000 acciones ordinarias. El registro indica un valor de mercado agregado de $3,632,946.95 para las acciones y una fecha de venta aproximada del 03/10/2025. El corredor designado es Fidelity Brokerage Services LLC, y las acciones cotizan en NASDAQ.

Las acciones fueron adquiridas mediante una concesión de opciones con fecha 01/04/2016, del emisor, con pago indicado como efectivo el 03/10/2025. El registro también reporta 79,438,094 acciones en circulación. Este aviso refleja la intención de vender conforme a la Regla 144 y no ejecuta una transacción por sí mismo.

PTC Therapeutics (PTCT)는 일반주 55,000주 매도를 위한 Form 144 통지를 제출했습니다. 제출서는 주식의 총 시장가치를 3,632,946.95달러로 표시하고 매도 예정일은 대략 2025년 10월 3일입니다. 지정 중개인은 Fidelity Brokerage Services LLC이고 주식은 NASDAQ에 상장되어 있습니다.

주식은 발행사로부터 2016년 1월 4일로 날짜를 가진 옵션 부여를 통해 취득되었으며, 2025년 10월 3일 현금으로 지불된 것으로 표시됩니다. 제출서는 또한 79,438,094주가 발행 주식으로 남아 있음을 보고합니다. 이 공고는 규칙 144에 따른 매도 의사를 반영하며 자체적으로 거래를 실행하지 않습니다.

PTC Therapeutics (PTCT) a déposé un avis Form 144 pour une vente proposée de 55 000 actions ordinaires. Le dossier indique une valeur marchande brute de 3 632 946,95 USD pour les actions et une date de vente approximative du 3 octobre 2025. Le courtier désigné est Fidelity Brokerage Services LLC, et les actions sont cotées sur NASDAQ.

Les actions ont été acquises via une attribution d’options datée du 4 janvier 2016, par l’émetteur, le paiement étant noté comme espèces le 3 octobre 2025. Le dossier rapporte également 79 438 094 actions en circulation. Cet avis reflète l’intention de vendre conformément à la règle 144 et ne réalise pas lui-même une transaction.

PTC Therapeutics (PTCT) legte eine Form 144-Mitteilung für einen vorgeschlagenen Verkauf von 55.000 Stammaktien ein. Die Unterlage listet einen aggregierten Marktwert von 3.632.946,95 USD für die Aktien und ein voraussichtliches Verkaufsdatum vom 3. Oktober 2025. Der designated Broker ist Fidelity Brokerage Services LLC, und die Aktien sind an der NASDAQ notiert.

Die Aktien wurden durch eine Optionsgewährung vom 4. Januar 2016 vom Emittenten erworben, mit der Zahlung, die am 3. Oktober 2025 als Bargeld vermerkt ist. Die Unterlage meldet außerdem 79.438.094 ausstehende Aktien. Diese Mitteilung spiegelt die Absicht wider, gemäß Regel 144 zu verkaufen, und führt selbst keinen Handel aus.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did PTCT disclose in this Form 144?

A proposed sale of 55,000 shares of common stock with an aggregate market value of $3,632,946.95.

When is the proposed sale date for PTCT shares?

The approximate sale date is 10/03/2025.

Which broker is listed for the PTCT Form 144 sale?

The filing names Fidelity Brokerage Services LLC as the broker.

On which exchange are the PTCT shares listed?

The shares are listed on NASDAQ.

How were the shares to be sold acquired?

They were acquired via an Option Granted - 01/04/2016 from the issuer, with cash payment dated 10/03/2025.

How many PTCT shares are outstanding according to the notice?

The filing reports 79,438,094 shares outstanding.

Does this Form 144 mean the sale has occurred?

No. It is a notice of proposed sale under Rule 144, not a completed transaction.
Ptc Therapeutics

NASDAQ:PTCT

PTCT Rankings

PTCT Latest News

PTCT Latest SEC Filings

PTCT Stock Data

5.26B
77.43M
2.47%
101.79%
8.36%
Biotechnology
Pharmaceutical Preparations
Link
United States
WARREN